Evidence map›Paper›PMID 31267169›Full record

ArticleJournal of molecular medicine (Berlin, Germany)2019

Correction to: STIM1 deficiency is linked to Alzheimer's disease and triggers cell death in SH-SY5Y cells by upregulation of L-type voltage-operated Ca

Carlos Pascual-Caro, Maria Berrocal, Aida M Lopez-Guerrero, Alberto Alvarez-Barrientos, Eulalia Pozo-Guisado, Carlos Gutierrez-Merino, Ana M Mata, Francisco Javier Martin-Romero

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of molecular medicine (Berlin, Germany), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Carlos Pascual-CaroDepartment of Biochemistry and Molecular Biology, School of Life Sciences and Institute of Molecular Pathology Biomarkers, University of Extremadura, Avenida de Elvas s/n, 06006, Badajoz, Spain.
Maria BerrocalDepartment of Biochemistry and Molecular Biology, School of Life Sciences and Institute of Molecular Pathology Biomarkers, University of Extremadura, Avenida de Elvas s/n, 06006, Badajoz, Spain.
Aida M Lopez-GuerreroDepartment of Biochemistry and Molecular Biology, School of Life Sciences and Institute of Molecular Pathology Biomarkers, University of Extremadura, Avenida de Elvas s/n, 06006, Badajoz, Spain.
Alberto Alvarez-BarrientosApplied Bioscience Facility, University of Extremadura, Avenida de Elvas s/n, 06006, Badajoz, Spain.
Eulalia Pozo-GuisadoDepartment of Cell Biology, School of Medicine and Institute of Molecular Pathology Biomarkers, University of Extremadura, Avenida de Elvas s/n, 06006, Badajoz, Spain.
Carlos Gutierrez-MerinoDepartment of Biochemistry and Molecular Biology, School of Life Sciences and Institute of Molecular Pathology Biomarkers, University of Extremadura, Avenida de Elvas s/n, 06006, Badajoz, Spain.
Ana M MataDepartment of Biochemistry and Molecular Biology, School of Life Sciences and Institute of Molecular Pathology Biomarkers, University of Extremadura, Avenida de Elvas s/n, 06006, Badajoz, Spain.
Francisco Javier Martin-RomeroDepartment of Biochemistry and Molecular Biology, School of Life Sciences and Institute of Molecular Pathology Biomarkers, University of Extremadura, Avenida de Elvas s/n, 06006, Badajoz, Spain. fjmartin@unex.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The original publication of this paper contains errors.

Identifiers

PMID31267169
PMCPMC6828000

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.